Citations

Showing 10 of 108104 citations.

Immunoproteomic Identification of Noncarbohydrate Antigens Eliciting Graft‐Specific Adaptive Immune Responses in Patients with Bovine Pericardial Bioprosthetic Heart Valves
Gates, Katherine V. , Xing, Qi., Griffiths, Leigh G. , Griffiths, Leigh G

Mayo Clinic

PROTEOMICS – Clinical Applications | December 13, 2018 | Volume: 13 | Issue: 4 | Pages: No page available

10.1002/prca.201800129 | PMID 30548925 Get It

PurposeThis case‐control retrospective discovery study is to identify antigenic bovine pericardium (BP) proteins that stimulate graft‐specific humoral immune response in patients implanted with glutaraldehyde fixed bovine pericardial (GFBP) heart valves.Experimental designBanked serum is collected from age‐ and sex‐matched patients who received either a GFBP or mechanical heart valve replacement. Serum IgG is isolated and used to generate poly‐polyclonal antibody affinity chromatography columns from each patient. Native and deglycosylated BP protein extracts are separately added to individual patient affinity chromatography columns, with unbound proteins washed through the column. Proteins captured in the affinity chromatography columns are submitted for proteomic identification. Differences between GFBP and mechanical heart valve replacement recipients are analyzed with Gaussian linearized modeling.ResultsCarbohydrate antigens overwhelm protein capture in the column, requiring BP protein deglycosylation prior to affinity chromatography. Nineteen BP protein antigens, which stimulated graft‐specific IgG production, are identified in patients who received GFBP valve replacements. Identified antigens are significantly over‐represented for calcium‐binding proteins.Conclusions and clinical relevancePatients implanted with GFBP valves develop a graft‐specific humoral immune response toward BP protein antigens, with 19 specific antigens identified in this work. The molecular functions of over‐represented antigens, specifically calcium‐binding proteins, may aid in understanding the underlying factors that contribute to structural valve deterioration.
Isolation and characterization of turkey bone marrow‐derived mesenchymal stem cells
Liu, Qian , Zhu, Yaxi , Qi, Jun , Amadio, Peter C. , Moran, Steven L. , Gingery, Anne , Zhao, Chunfeng , Liu, Qian , Gingery, Anne

Mayo Clinic

Journal of Orthopaedic Research | December 13, 2018 | Volume: 37 | Issue: 6 | Pages: 1419-1428

10.1002/jor.24203 | PMID 30548886 Get It

ABSTRACTFlexor tendon injury is often associated with suboptimal outcomes and results in substantial digit dysfunction. Stem cells have been isolated from several experimental animals for the growing interest and needs of utilizing cell‐based therapies. Recently, turkey has been developed as a new large animal model for flexor tendon research. In the present study, we reported the isolation and characterization of bone marrow‐derived mesenchymal stem cells (BMSCs) from 8‐ to 12‐month‐old heritage‐breed turkeys. The isolated cells demonstrated fibroblast‐like morphology, clonogenic capacity, and high proliferation rate. These cells were positive for surface antigens CD90, CD105, and CD44, but were negative for CD45. The multipotency of turkey BMSCs was determined by differentiating cells into osteogenic, adipogenic, chondrogenic, and tenogenic lineages. There was upregulated gene expression of tenogenic markers, including mohawk, tenomodulin, and EGR1 as well as increased collagen synthesis in BMP12 induced cells. The successful isolation and verification of bone marrow‐derived MSCs from turkey would provide opportunities of studying cell‐based therapies and developing new treatments for tendon injuries using this novel preclinical large animal model. © 2018 Orthopaedic Research Society. Published by Wiley Periodicals, Inc. J Orthop Res 37:1419–1428, 2019.
Pediatric tinea capitis caused by Trichophyton violaceum and Trichophyton soudanense in Rochester, Minnesota, United States
Grigoryan, Konstantin V., Tollefson, Megha M. , Olson, Meredith A., Newman, Catherine C.

Mayo Clinic

International Journal of Dermatology | December 13, 2018 | Volume: 58 | Issue: 8 | Pages: 912-915

10.1111/ijd.14352 | PMID 30548845 Get It

AbstractBackgroundTinea capitis is a common pediatric dermatophyte infection. Its main pathogen in the United States is Trichophyton tonsurans accounting for greater than 95% of the infections. Other pathogens including Trichophyton violaceum and Trichophyton soudanense are common in Africa. Although rare in the United States, their prevalence is increasing, possibly because of immigration patterns. We evaluated the demographic characteristics, treatments, and resolution among pediatric patients with T. violaceum and T. soudanense infections.MethodsRetrospective chart review of patients from Mayo Clinic in Rochester, Minnesota, United States, with cultures positive for T. violaceum and T. soudanense from 1997 to 2014. Age at presentation, ethnic background, date and location of culture, and treatment were extracted.ResultsIn total, 81 children (age <18 years) were identified as positive for T. violaceum and T. soudanense (mean [range] age, 6.0 [1–17] years). Race/ethnicity of 67 patients (82.7%) was African; four, African‐American; three, white; two, Asian; and five, unknown. After culture identification, 64 patients (79.0%) received griseofulvin; five, terbinafine; and three, itraconazole; nine patients had no documented oral antifungal therapy. Of 28 patients not lost to follow‐up, median time to clinical cure was 2.3 months (interquartile range, 2.8 months).ConclusionT. violaceum and T. soudanense are tinea capitis pathogens, most common among patients of African descent. The pathogens may be underrecognized because such tinea capitis causes are rare in the United States. Most patients had direct contact with persons who had similar symptoms, suggesting contagious nature. Griseofulvin and terbinafine appear to be acceptable treatments against these organisms.
Prevalence and Clinical Factors of Migraine in Patients With Spontaneous Coronary Artery Dissection
Kok, Susan N., Cutrer, F. Michael , Gulati, Rajiv , Best, Patricia J.M. , Tweet, Marysia S. , Hayes, Sharonne N. , Raphael, Claire E.

Mayo Clinic

Journal of the American Heart Association | December 13, 2018 | Volume: 7 | Issue: 24 | Pages: No page available

10.1161/jaha.118.010140 | PMID 30561271 Get It

Background Spontaneous coronary artery dissection (SCAD) is a cause of acute coronary syndrome predominantly in women without usual cardiovascular risk factors. Many have a history of migraine headaches, but this association is poorly understood. This study aimed to determine migraine prevalence among SCAD patients and assess differences in clinical factors based on migraine history. Methods and Results A cohort study was conducted using the Mayo Clinic SCAD “Virtual” Multi‐Center Registry composed of patients with SCAD as confirmed on coronary angiography. Participant‐provided data and records were reviewed for migraine history, risk factors, SCAD details, therapies, and outcomes. Among 585 patients (96% women), 236 had migraine history; the lifetime and 1‐year prevalence of migraine were 40% and 26%, respectively. Migraine was more common in SCAD women than comparable literature‐reported female populations (42% versus 24%, P <0.0001; 42% versus 33%, P <0.0001). Among all SCAD patients, those with migraine history were more likely to be female (99.6% versus 94%; P =0.0002); have SCAD at a younger age (45.2±9.0 years versus 47.6±9.9 years; P =0.0027); have depression (27% versus 17%; P =0.025); have recurrent post‐SCAD chest pain at 1 month (50% versus 39%; P =0.035); and, among those assessed, have aneurysms, pseudoaneurysms, or dissections (28% versus 18%; P =0.018). There was no difference in recurrent SCAD at 5 years for those with versus without migraine (15% versus 19%; P =0.39). Conclusions Many SCAD patients have a history of migraine. SCAD patients with migraine are younger at the time of SCAD; have more aneurysms, pseudoaneurysms, and dissections among those imaged; and more often report a history of depression and post‐SCAD chest pain. Clinical Trial Registration URL: https://www.clinicaltrials.gov . Unique identifiers: NCT01429727, NCT01427179.
Cardiac resynchronization therapy improves myocardial conduction
Yang, Mei , Li, Xuping , Li, Yi‐Gang , Zhou, Shenghua , Liang, Jinjun , Wu, Gang , Munoz, Freddy Del‐Carpio , Chen, Horng H. , Friedman, Paul A. , Cha, Yong‐Mei , Yang, Dachun, Del-Carpio Munoz, Freddy , Friedman, Paul A , Cha, Yong-Mei , Yang, Dachun, Zhou, Shenghua

Mayo Clinic

Pacing and Clinical Electrophysiology | December 13, 2018 | Volume: 42 | Issue: 2 | Pages: 238-246

10.1111/pace.13581 | PMID 30548634 Get It

AbstractBackgroundCardiac resynchronization therapy (CRT) reverses left ventricular remodeling and improves left ventricular systolic function. However, little is known about whether CRT improves ventricular conduction.ObjectiveTo determine the relationship between CRT response and QRS narrowing.MethodsThe study included consecutive patients who underwent CRT with defibrillator (CRT‐D) implantation between January 2002 and December 2012 and had subsequent generator replacement (GR). At the time of GR, super‐responder was defined as those who had left ventricular ejection fraction (LVEF) of 50% or more; patients who had an LVEF of 36–49% with an increase of more than 5% were considered responders, and the others were nonresponders. All patients were assessed 6 months after CRT‐D implantation and at the time of GR.ResultsOf 114 study patients, 58 (50.9%) were nonresponders, 29 (25.4%) responders, and 27 (23.7%) super‐responders. QRS narrowing at 6 months was significant in super‐responders (175.4 ± 21.4 to 159.7 ± 20.7 ms, P = 0.001) and responders (169.0 ± 21.3 to 157.7 ± 17.6 ms, P = 0.008). At time of GR, only super‐responders had further QRS narrowing (159.7 ± 20.7 to 146.3 ± 19.2 ms, P < 0.001). QRS duration change after 6 months was independently associated with super‐response (hazard ratio: 1.20 for every 5 ms QRS duration narrowing; 95% confidence interval, 1.06–1.38; P = 0.005), and QRS narrowing of 10 ms or more was associated with lower risk of all‐cause mortality after GR.ConclusionContinuous QRS narrowing after CRT, as an electrical marker, is associated with a super‐response to CRT. Further QRS narrowing 6 months after CRT implantation was associated with lower risk of mortality after GR.
New subcutaneous PowerFlow port results in cost and time‐savings in a busy outpatient apheresis clinic
Arnesen, Christine, Gunn, Christina, Boshell, Michael N., Pham, Huy P. , Guillory, Bryan, Adamski, Jill , Williams, Lance A , Pham, Huy P , Marques, Marisa B.

Mayo Clinic

Journal of Clinical Apheresis | December 13, 2018 | Volume: 34 | Issue: 4 | Pages: 482-486

10.1002/jca.21678 | PMID 30548646 Get It

AbstractMany vascular access options, such as subcutaneous ports, are currently on the market for use in both medication infusion and for procedures, such as therapeutic plasma exchange and extracorporeal photopheresis. We compared the cost and time necessary to complete apheresis procedures using either Angiodynamic's Vortex or Bard's PowerFlow subcutaneous ports by reviewing our experience on two patients undergoing long‐term apheresis treatments with at least 10 procedures with each type of port. We analyzed the cost of needles and thrombolytic therapy, staff time, overall procedure length, and the total time the patient was in the apheresis unit. We also compared flow rates and alarm rates between the two ports. In this small pilot study, use of the PowerFlow port resulted in significant cost and time savings, with mixed results for flow rates. Our results need to be confirmed in a larger patient population prior to recommending wide implementation of Bard's PowerFlow port.
Role of QRS Fragmentation for Risk Stratification in Adults With Tetralogy of Fallot
Egbe, Alexander C. , Miranda, William R. , Mehra, Nandini , Ammash, Naser M., Missula, Venkata, Madhavan, Malini , Deshmukh, Abhishek , Abdelsamid, Mohamed Farouk, Kothapalli, Srikanth, Connolly, Heidi M. , Missula, Venkata R, Farouk Abdelsamid, Mohamed

Mayo Clinic

Journal of the American Heart Association | December 13, 2018 | Volume: 7 | Issue: 24 | Pages: No page available

10.1161/jaha.118.010274 | PMID 30561260 Get It

Background Patients with tetralogy of Fallot ( TOF ) remain at risk for cardiovascular events despite successful repair. Some of the current risk stratification tools require advanced imaging and invasive studies, and hence are difficult to apply to routine patient care. A recent study showed that QRS fragmentation ( QRS ‐f) is predictive of mortality in patients with TOF. The current study aims to validate this result by assessing whether severity of QRS ‐f could predict all‐cause mortality in a different TOF population. Methods and Results The authors reviewed the Mayo Adult Congenital Heart Disease database for patients with TOF who had ECG from 1990–2017. QRS ‐f was defined as notches in QRS complex in ≥2 contiguous leads on ECG , not related to bundle branch block, and classified as none, mild (≤3 leads), moderate (4 leads), or severe (≥5 leads). Of 465 patients (age 37±14 years) in the study, QRS ‐f was present in 161 (35%): mild (n=43, 9%), moderate (n=77, 17%), and severe (n=41, 9%). There were 55 deaths (12%) during 13.6±8.2 years of follow‐up. Severity of QRS ‐f remained an independent predictor of all‐cause mortality after adjustment for other ECG parameters, patient demographics, and atrial and ventricular arrhythmia (hazard ratio, 1.74 per class; 95% confidence interval, 1.08–2.93 [ P =0.041]). Conclusions The presence of severe QRS ‐f may be used as complementary data to the usual clinical indices to determine whether interventions such as invasive electrophysiology study should be performed in patients with nonsustained ventricular tachycardia or to proceed with pulmonary valve replacement in patients with severe pulmonary regurgitation with ventricular volumes below the guideline‐directed threshold for intervention.
A National Survey of Transplant Surgeons and Nephrologists on Implementing Apolipoprotein L1 ( APOL1 ) Genetic Testing Into Clinical Practice
Gordon, Elisa J. , Wicklund, Catherine , Lee, Jungwha , Sharp, Richard R. , Sharp, Richard R , Friedewald, John J.

Mayo Clinic

Progress in Transplantation | December 13, 2018 | Volume: 29 | Issue: 1 | Pages: 26-35

10.1177/1526924818817048 | PMID 30541404 Get It

Introduction: There is debate over whether Apolipoprotein L1 (APOL1) gene risk variants contribute to African American (AA) live donors’ (LD) increased risk of kidney failure. Little is known about factors influencing physicians’ integration of APOL1 genetic testing of AA LDs into donor evaluation. Design: We conducted a cross-sectional survey, informed by Roger’s Diffusion of Innovations theory, among nephrology and surgeon members of the American Society of Nephrology, American Society of Transplantation, and American Society of Transplant Surgeons about their practices of and attitudes about APOL1 genetic testing of AA potential LDs. Descriptive statistics and bivariate analyses were performed. Results: Of 383 completed surveys, most physicians believed that APOL1 testing can help AA LDs make more informed donation decisions (87%), and the addition of APOL1 testing offers better clinical information about AA LD’s eligibility for donation than existing evaluation approaches (74%). Among respondents who evaluate LDs (n = 345), 63% would definitely or probably begin or continue using APOL1 testing in the next year, however, few use APOL1 testing routinely (4%) or on a case-by-case basis (14%). Most did not know the right clinical scenario to order APOL1 testing (59%), but would use educational materials to counsel AA LDs about APOL1 testing (97%). Discussion: Although physicians were highly supportive of APOL1 genetic testing for AA LDs, few physicians use APOL1 testing. As more physicians intend to use APOL1 testing, an ethical framework and clinical decision support are needed presently to assist clinicians in clarifying the proper indication of APOL1 genetic testing.
Lumbar Epidural Abscesses: A Systematic Review
Leeuw, Charles N. de , Fann, Patrick R., Tanenbaum, Joseph E., Buchholz, Avery L., Freedman, Brett A. , Steinmetz, Michael P. , Mroz, Thomas E. , de Leeuw, Charles N

Mayo Clinic

Global Spine Journal | December 13, 2018 | Volume: 8 | Issue: 4_suppl | Pages: 85S-95S

10.1177/2192568218763323 | PMID 30574443 Get It

Study Design: Systematic review. Objectives: Spinal epidural abscesses (SEAs) are rare, but when missed or when diagnosis is delayed, SEA can lead to permanent neurological impairment or death. Limited information exists on the optimal treatment modalities for SEA, especially in the lumbar spine. We synthesize the current literature to identify the clinical features, diagnosis, management, and outcomes of lumbar SEA. Methods: Queries in 4 databases—EMBASE, MEDLINE, Scopus, and Web of Science—were performed using comprehensive search terms to locate published literature on lumbar SEA. Results: Ten articles reporting results for 600 cases of lumbar SEA were included, published between 2000 and 2017. Negative prognostic factors included diabetes, older age, methicillin-resistant Staphylococcus aureus, immune compromise, and more severe disease at presentation. Early first-line surgically treated patients responded better, specifically in terms of motor recovery, than those undergoing medical management or failing medical treatment, despite generally worse initial presentation. Elevated C-reactive protein, leukocytosis, and positive blood cultures predicted medical management failure. Conclusions: This systematic review provides guidance to neurological and orthopedic spine surgeons seeking the best treatment for lumbar-localized SEA. This study is limited by a dearth of high-quality publications to support evidenced-based management recommendations. Surgical treatment appears to provide better outcomes than medical treatment alone, especially in those who present with a motor deficit. Further investigation is needed to confirm this finding. What is clear is that early recognition and treatment remains crucial to minimizing morbidity and mortality of SEA.
Surgical Site Infections in Spine Surgery: Preoperative Prevention Strategies to Minimize Risk
Spina, Nicholas , Aleem, Ilyas , Lawrence, Brandon D. , Nassr, Ahmad

Mayo Clinic

Global Spine Journal | December 13, 2018 | Volume: 8 | Issue: 4_suppl | Pages: 31S-36S

10.1177/2192568217752130 | PMID 30574435 Get It

Study Design: Literature review. Objectives: A review of the literature identifying preoperative risk factors for developing surgical site infections after spine surgery and discussion of the preventive strategies to minimize risks. Methods: A review of the literature and synthesis of the data to provide an updated review on the preoperative management of surgical site infection. Results: Preoperative prevention strategies of reducing surgical site infections in spine surgery remains a challenging problem. Careful mitigation of modifiable patient comorbidities, blood glucose control, smoking, obesity, and screening for pathologic microorganisms is paramount to reduce this risk. Individualized antibiotic regimens, skin preparation, and hand hygiene also play a critical role in surgical site infection prevention. Conclusions: This review of the literature discusses the preoperative preventive strategies and risk management techniques of surgical site infections in spine surgery. Significant decreases in surgical site infections after spine surgery have been noted over the past decade due to increased awareness and implementation of the prevention strategies described in this article. However, it is important to recognize that prevention of surgical site infection requires a system-wide approach that includes the hospital system, the surgeon, and the patient. Continued efforts should focus on system-wide implementation programs including careful patient selection, individualized antibiotic treatment algorithms, identification of pathologic organisms, and preoperative decolonization programs to further prevent surgical site infections and optimize patient outcomes.